Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA”
164 pharma patents match "BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 164 pharmaceutical patents matching "BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10945962
Controlled-release peptide compositions and uses thereof
granted -
US 10933071
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 10881630
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 10876134
Gene therapy for juvenile batten disease
granted -
US 10874752
MIBG analogs and uses thereof
granted -
US 10821178
Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells
granted -
US 10799620
Ring and tubular structures and methods of synthesis and use thereof
granted -
US 10729643
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
granted -
US 10723764
Anti-microbial peptides and methods of use thereof
granted -
US 10647964
Non-neuroinvasive viruses and uses thereof
granted -
US 10633643
Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells
granted -
US 10591468
Circulating antibodies against MAA adducts as biomarker for coronary artery disease
granted -
US 10531680
Creatine ester pronutrient compounds and formulations
granted -
US 10485809
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 10485800
Mixed lineage kinase inhibitors for HIV/AIDS therapies
granted -
US 10414725
Pyrrolomycins and methods of using the same
granted -
US 10363282
Analogs of C5a and methods of using same
granted -
US 10342771
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 10220002
Controlled-release peptide compositions and uses thereof
granted -
US 10206897
Creatine ester anti-inflammatory compounds and formulations
granted -
US 10144767
Anti-microbial peptides and coatings
granted -
US 10081668
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted -
US 10053706
Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests
granted -
US 10023652
Method of targeting glycoproteins to treat cancer
granted